3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
10
fludarabine
7
pomalidomide
5
pembrolizumab
5
Dexamethasone
5
daratumumab
4
obinutuzumab
3
glofitamab
3
fludarabine phosphate
3
abemaciclib
3
Rituximab
3
Melphalan
3
Etoposide
3
Bortezomib
3
venetoclax
2
tocilizumab
2
palbociclib
2
cemiplimab
2
Temozolomide
2
Oxaliplatin
2
Nivolumab
2
Mesna
2
Letrozole
2
Injections
2
Immunotherapy, Adoptive
2
Gemcitabine
2
Biopsy
2
zanubrutinib
1
tislelizumab
1
tipifarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Vorinostat
×
30 days
×
Clear all
No trials found.